v3.26.1
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Operating expenses      
Research and development $ 182,373 $ 126,095 $ 206,298
General and administrative 52,015 60,754 71,023
Total operating expenses 234,388 186,849 277,321
Loss from operations (234,388) (186,849) (277,321)
Interest income 4,517 11,148 16,733
Interest expense 0 0 (13)
Other income (expense), net (96) (506) 110
Net loss $ (229,967) $ (176,207) $ (260,491)
Net loss per share common share, basic $ (4.32) $ (3.35) $ (4.97)
Net loss per share common share, diluted $ (4.32) $ (3.35) $ (4.97)
Weighted-average shares of common stock outstanding used in computing net loss per common share, basic 53,208,311 52,583,148 52,414,256
Weighted-average shares of common stock outstanding used in computing net loss per common share, diluted 53,208,311 52,583,148 52,414,256
Other comprehensive income (loss)      
Change in unrealized gains (losses) related to available-for-sale debt securities, net of tax $ 0 $ 0 $ 1,307
Total other comprehensive income (loss) 0 0 1,307
Comprehensive loss $ (229,967) $ (176,207) $ (259,184)